Detalhe da pesquisa
1.
Comparison of acute versus stable coronary syndrome in patients treated with the Magmaris scaffold: Two-year results from the Magmaris Multicenter Italian Registry.
Cardiovasc Revasc Med
; 57: 53-59, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37543502
2.
Sustained Safety and Efficacy of Magnesium Reabsorbable Scaffold: 2-Year Follow-Up Analysis From First Magmaris Multicenter Italian Registry.
Cardiovasc Revasc Med
; 41: 69-75, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35256294
3.
ImpaCt of an Optimal Implantation Strategy on Absorb Long-Term Outcomes: The CIAO Registry.
Cardiovasc Revasc Med
; 30: 1-8, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077393
4.
Magmaris: a new generation metallic sirolimus-eluting fully bioresorbable scaffold: present status and future perspectives.
J Thorac Dis
; 9(Suppl 9): S903-S913, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28894596
5.
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions.
Cardiovasc Revasc Med
; 18(5S1): S4-S9, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28314675
6.
A Prospective Evaluation of a Pre-Specified Absorb BVS Implantation Strategy in ST-Segment Elevation Myocardial Infarction: The BVS STEMI STRATEGY-IT Study.
JACC Cardiovasc Interv
; 10(18): 1855-1864, 2017 09 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935077
7.
One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS).
EuroIntervention
; 13(4): 424-431, 2017 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28504219